share_log

Abeona Therapeutics | 8-K: Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Abeona Therapeutics | 8-K: Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission

Abeona Therapeutics | 8-K:Abeona Therapeutics® 公布2024年第二季度财务业绩并结束与美国食品药品管理局的A类会议,以就即将提交的PZ-cel BLA重新提交达成一致
美股SEC公告 ·  2024/08/12 19:35
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息